Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Stomach Neoplasms × Etoposide × Clear all

Phase

Phase 3 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lymphoma 33 Leukemia 32 Small Cell Lung Carcinoma 30 Leukemia, Myeloid, Acute 24 Precursor Cell Lymphoblastic Leukemia-Lymphoma 23 Lung Neoplasms 22 Lymphoma, Large B-Cell, Diffuse 17 Neuroblastoma 14 Lymphoma, Non-Hodgkin 13 Hodgkin Disease 13 Leukemia, Erythroblastic, Acute 12 Carcinoma, Non-Small-Cell Lung 12 Leukemia, Myelomonocytic, Acute 11 Leukemia, Monocytic, Acute 11 Leukemia, Megakaryoblastic, Acute 11 Sarcoma 10 Lymphoma, Follicular 9 Burkitt Lymphoma 9 Lymphoma, Large-Cell, Immunoblastic 8 Myelodysplastic Syndromes 7 Testicular Neoplasms 6 Teratoma 6 Congenital Abnormalities 6 Anemia, Refractory, with Excess of Blasts 6 Endodermal Sinus Tumor 5 Central Nervous System Neoplasms 5 Testicular Germ Cell Tumor 4 Rhabdomyosarcoma 4 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Neuroectodermal Tumors, Primitive, Peripheral 4

Interventions

Oxaliplatin 51 Capecitabine 42 Fluorouracil 30 Cisplatin 30 S 1 (combination) 21 Docetaxel 16 Paclitaxel 15 Leucovorin 14 pembrolizumab 10 apatinib 10 Irinotecan 10 titanium silicide 9 XELOX 9 Nivolumab 8 Epirubicin 8 Drug Therapy 8 Hyperthermic Intraperitoneal Chemotherapy 7 Tegafur 6 Radiotherapy 6 Neoadjuvant Therapy 6 gimeracil 5 Trastuzumab 5 Chemotherapy, Adjuvant 5 Surgical Procedures, Operative 4 S-1 plus cisplatin 4 Ramucirumab 4 Gastrectomy 4 zolbetuximab 3 tislelizumab 3 sintilimab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02338518 2023-09-29

SVOSA

Jinling Hospital, China

Phase 3 Unknown

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡